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Center, CSIC-ICCC, IIB-Sant Pau, Hospital de la Santa Creu i Sant Pau, Barcelona, SpainABSTRACT Aggregated low-density lipoprotein (agLDL), one of the main LDL modifications in the arterial intima, contributes
to massive intracellular cholesteryl ester (CE) accumulation in human vascular smooth muscle cells (VSMC), which are major
producers of elastin in the vascular wall. Our aim was to analyze the levels, physical structure, and molecular mobility of tropoe-
lastin produced by agLDL-loaded human VSMC (agLDL-VSMC) versus that produced by control VSMC. Western blot analysis
demonstrated that agLDL reduced VSMC-tropoelastin protein levels by increasing its degradation rate. Moreover, our results
demonstrated increased levels of precursor and mature forms of cathepsin S in agLDL-VSMC. Fourier transform infrared anal-
ysis revealed modifications in the secondary structures of tropoelastin produced by lipid-loaded VSMCs. Thermal and dielectric
analyses showed that agLDL-VSMC tropoelastin has decreased glass transition temperatures and distinct chain dynamics that,
in addition to a loss of thermal stability, lead to strong changes in its mechanical properties. In conclusion, agLDL lipid loading of
human vascular cells leads to an increase in cathepsin S production concomitantly with a decrease in cellular tropoelastin
protein levels and dramatic changes in secreted tropoelastin physical structure. Therefore, VSMC-lipid loading likely determines
alterations in the mechanical properties of the vascular wall and plays a crucial role in elastin loss during atherosclerosis.INTRODUCTIONThe synthesis of elastin, the main extracellular matrix
protein in the media of the arterial and aortic walls, occurs
during late fetal and early postnatal life and stops in the
aortic tissue of adults (1). One of the mechanisms that
contribute to the lack of elastin synthesis in adults is the
rapid degradation of elastin mRNA through the action of
specific miRNA (2). Although mature elastic fibers are
extremely stable in humans (3,4), a progressive loss of
vascular elastin content leading to increased vascular stiff-
ening occurs in aging (5,6) and atherosclerosis (7,8).
Vascular smooth muscle cells (VSMCs), the main cellular
component of the vascular wall, are also the major pro-
ducers of tropoelastin, the soluble precursor of elastin.
However, VSMCs in atherosclerotic lesions are unable to
produce normal elastic fibers (9) due to atherosclerotic
risk factors such as diabetes and associated hyperglycemia,
endothelial dysfunction, and inflammation (10,11). It is
known that experimental hypercholesterolemia decreases
the elastin content of the wall in vivo (12) and in in vitro
systems (13). However, the role of hypercholesterolemia in
the altered elastogenic capacity of VSMCs and the possible
mechanisms involved are almost completely unknown.
Accumulation of extracellular matrix-retained low-density
lipoproteins (LDL) in the arterial intima is crucial for the
onset and progression of atherosclerosis (14,15). The incor-
poration of matrix-retained LDL by macrophages (16,17)Submitted March 14, 2012, and accepted for publication June 20, 2012.
*Correspondence: valerie.samouillan@univ-tlse3.fr or cllorente@csic-iccc.
org
Editor: Edward Egelman.
 2012 by the Biophysical Society
0006-3495/12/08/0532/9 $2.00and VSMC (18,19) leads to the accumulation of cholesteryl
ester (CE) and formation of foam cells. Macrophages
become foam cells through the uptake of diversely modified
LDLs, whereas the aggregation of LDLs seems to be a key
condition for lipid accumulation in VSMCs (21–23). Aggre-
gated LDLs (agLDLs) obtained by vortexing LDL in vitro
share structural characteristics with LDL aggregates present
in atherosclerotic lesions (24). Our previous results showed
that hypercholesterolemia can increase the capacity of
VSMCs to take up LDL from the intima by regulating
cellular LDL receptor-related protein 1 (LRP1) (25), the
receptor for agLDL uptake in human VSMCs (18). Intracel-
lular cholesterol accumulation alters proteoglycan composi-
tion (26) and collagen assembly (27) in VSMCs. However, it
is unknown whether intracellular lipid can change the levels
or the physical characteristics of the tropoelastin synthesized
by human VSMCs.
Tropoelastin contains glycine amino acids (28), which
account for one-third of its composition, and several lysine
derivatives that serve as covalent cross-links between
protein monomers (29). Elastin can be thus considered
as a three-dimensional network with 60–70 amino acids
between two cross-linking points, with the alternation of
hydrophilic cross-linking domains and dynamic hydro-
phobic domains with fluctuating turns, buried hydrophobic
residues, and main-chain polar atoms forming hydrogen
(H)-bonds with water (30–33). This peculiar molecular
architecture determines its elastic properties, insolubility,
and resistance to proteolysis (34). Our goal in this work
was to analyze tropoelastin levels and the physical structure
and molecular mobility of tropoelastin produced byhttp://dx.doi.org/10.1016/j.bpj.2012.06.034
Lipid-Loaded Vascular Cells, Tropoelastin Changes 533agLDL-lipid-loaded human VSMCs in comparison with
that produced by control VSMCs.
For this purpose, we combined cellular and molecular
biology techniques with polymer characterization tech-
niques that were previously shown to be efficient for assess-
ing the molecular architecture and chain dynamics of
proteins (35–37).MATERIALS AND METHODS
Cellular and molecular biology techniques
Human VSMCs
Primary cultures of human VSMCs were obtained from nonatherosclerotic
areas of human coronary arteries from hearts explanted during heart trans-
plantation at the Hospital of Santa Creu i Sant Pau as previously described
(18,19). The transplanted patients were men between the ages of 40 and
60 years. The explants were incubated at 37C in a humidified atmosphere
of 5% CO2. Cells grown from the explants were suspended in a solution of
trypsin/EDTA and subcultured. They grew in monolayers in medium
199 supplemented with 20% fetal calf serum and 2% human serum,
2 mmol/L L-glutamine, 100 U/mL penicillin G, and 100 mg/mL strepto-
mycin (GIBCO Laboratories, Gaithersburg, MD). The study was approved
by the institutional ethics committee of the Hospital of Santa Creu i Sant
Pau and conducted in accordance with the Declaration of Helsinki.
LDL isolation and modification
Human LDL (d1.019-d1.063 g/mL) was obtained from the pooled sera of nor-
mocholesterolemic volunteers by sequential ultracentrifugation. The LDLs
were dialyzed and LDL protein concentration was determined according to
the bicinchoninic method, and cholesterol concentration was determined
with the use of a commercial kit (Roche Molecular Biochemical,
Boulogne-Billancourt, France). The LDLs used in the experiments were
<48 h old. The purity of the LDLs was assessed by agarose gel electropho-
resis (Paragon system; Beckmann Coulter, Brea, CA) (18,19).
AgLDLs were prepared by vortexing LDLs in phosphate-buffered saline
(PBS) at room temperature. The formation of LDL aggregates by vortexing
was monitored by measuring the turbidimetry (absorbance at 680 nm) as
previously described (18,19). The precipitable fraction of particles obtained
by vortexing was similar in size to the largest particles obtained by incuba-
tion with versican (19).
Determination of intracellular free CE and triglyceride content
VSMCs were incubated with agLDL (50 mg/mL) for 15 days. After the
lipoprotein incubation was completed, the cells were exhaustively washed
(twice with PBS, twice with PBS-1% BSA, and twice with PBS-1% BSA-
heparin 100 U/mL) before they were harvested into 1 mL of 0.15 mol/L
NaOH. Lipid extraction was performed as previously described (18,19).
Three different concentrations of standards (a mixture of cholesterol and
cholesterol palmitate) were applied to thin-layer chromatography plates.
Spots corresponding to free cholesterol (FC), triglycerides, and CE in the
thin-layer chromatography were quantified by densitometry against the
standard curve of cholesterol, triglycerides, and cholesterol palmitate,
respectively, using a computing densitometer (Phosphorimager model
445 SI; Molecular Dynamics, Sunnyvale, CA).
Determination of elastin gene expression by real-time
polymerase chain reaction
Total RNA was isolated by Tripure isolation reagent (Roche Molecular
Biochemicals) according to the manufacturer’s protocol. Tropoelastin
mRNA expression levels were determined by real-time polymerase chainreaction (PCR; Life Technologies, Foster City, CA) using Assays-on-
Demand (Hs00355783_m1; Applied Biosystems, Foster City, CA). Human
gapdh (4326317E; Applied Biosystems) was used as internal control, and
PCR was performed on the ABIPRISM7000 detection system. The
threshold cycle (Ct) values were determined and normalized to the house-
keeping gene.
Western blot analysis
Blots were incubated with monoclonal antibodies against human elastin
(sc-166369, dilution 1:50; Santa Cruz Biotechnology, Santa Cruz, CA) or
with monoclonal antibodies against human cathepsin (sc-271619; dilution
1:100; Santa Cruz Biotechnology). Elastin (F-5) is a mouse monoclonal
antibody raised against amino acids 431–730 of elastin of human origin,
and cathepsin S (E-3) is a mouse monoclonal antibody that is specific for
an epitope mapping between amino acids 302 and 331 at the C-terminus
of cathepsin S of human origin, and recognizes precursor (37 KDa) and
mature (24 KDa) cathepsin S. To test equal protein loading for the different
samples, blots were also incubated with monoclonal antibodies against
human b-actin (ab8226-100, dilution 1:5000; Abcam Biochemicals,
Cambridge, MA). The antibodies used for Western blotting detected
cellular but not secreted tropoelastin.
Measurement of cellular tropoelastin protein stability
in control and lipid-loaded VSMCs
To measure the stability of tropoelastin protein in human VSMCs, we
preexposed the cells to agLDL (50 mg/mL) for 48 h. Cycloheximide
(100 mmol/L) was then added and cell cultures were harvested at various
time points after cycloheximide treatment (12, 24, and 48 h), and collected
in lysis buffer. The protein was then processed for Western blot analysis.
The stability of the tropoelastin protein was assessed according to the
proportion of the initial protein that remained after cycloheximide
treatment.Physical techniques
For physical techniques, cell supernatants were centrifuged to remove lipids
that were not taken up by the cells and cellular debris. The samples were
then freeze-dried before tropoelastin physical characterizations were
obtained. Fourier transform infrared analysis (FTIR), thermogravimetric
analysis (TGA), differential scanning calorimetry (DSC), and dynamic
dielectric spectrometry (DDS) are described in the Supporting Material.RESULTS AND DISCUSSION
Fig. 1 shows that agLDL (50 mg/mL, 15 days) induced
a strong intracellular accumulation of CEs in a dose-depen-
dent manner in human VSMCs, consistent with the high
capacity of agLDL to induce foam cell formation from
VSMCs previously described by our group (18,19).
Real-time PCR results (Fig. 2) demonstrated that control
and lipid-loaded VSMCs showed the same pattern of tropoe-
lastin mRNA expression with time. The lack of effect of
agLDL on tropoelastin mRNA expression suggests that
agLDL influences a protein’s expression levels by modu-
lating its degradation. To assess whether agLDL could influ-
ence tropoelastin protein stability, we preexposed human
VSMCs to agLDL followed by addition of cycloheximide,
an inhibitor of translation. As shown in Fig. 3, the
percentage of initial cellular tropoelastin protein remained
constant in the control VSMCs. In contrast, cellularBiophysical Journal 103(3) 532–540
FIGURE 1 VSMCs were exposed to increasing concentrations (10, 25,
and 50 mg/mL) of agLDL for 15 days. Cells were then collected and lipid
extraction was performed as explained in Materials and Methods. Thin-
layer chromatography shows intracellular CE and FC bands. Results are
expressed as micrograms of cholesterol per milligram of protein, and are
shown as the mean 5 SE of three experiments performed in duplicate.
*p < 0.05, versus control VSMC.
FIGURE 3 VSMCs were preexposed to agLDL (50 mg/mL) for 48 h,
followed by incubation with cycloheximide (100 mmol/L) for the indicated
times. Unchanged levels of b-actin are shown as loading control. Line
graphs show the percentage of the value before the addition of cyclohexi-
mide. Results are expressed as the mean 5 SE of two independent
experiments performed in triplicate. *p < 0.05 versus control VSMC.
534 Samouillan et al.tropoelastin levels decayed by ~40% in VSMCs exposed to
agLDL for 48 h. These findings suggest that lipid loading
modulates the half-life of tropoelastin in human VSMCs.
In fact, cellular tropoelastin protein levels were significantly
downregulated in VSMC exposed to agLDL for 48 h
(agLDL: 35.98 5 0.75 a.u. vs. 67.34 5 3.23 a.u.,
p < 0.05) and 96 h (agLDL: 4.71 5 0.66 a.u. vs.FIGURE 2 VSMCs were exposed to agLDL (50 mg/mL) for increasing
periods of time (8, 16, 24, 48, and 96 h). Real-time PCR quantification of
tropoelastin mRNA levels was performed. Data were processed with
a specially designed software program based on Ct values, normalized to
GAPDH mRNA, and expressed as the mean 5 SE of three independent
experiments performed in duplicate.
Biophysical Journal 103(3) 532–54063.185 5.65 a.u., p < 0.05) (Fig. 4, A and B), consistently
with the downregulatory effects of hypercholesterolemia on
aortic elastin levels in in vivo models (12,13). In contrast,
cellular tropoelastin protein levels were not altered during
the test days in control VSMCs. Elastic tissue is the most
stable component of the vascular wall, and therefore the
lower VSMC tropoelastin contribution by lipid-loaded
VSMC could be negligible for the extracellular matrix.
Remarkably, in atherosclerosis, a progressive loss of exist-
ing elastic fibers occurs as a result of different cardiovas-
cular risk factors, and most defects in the progression of
vascular elastin loss are associated with enzymatic degrada-
tion. Our results show that agLDL (50 mg/mL, 96 h) signif-
icantly increased both cellular precursor (Fig. 4, A and C)
and mature (Fig. 4, A and D) forms of cathepsin S by
21- and 4-fold, respectively. Cathepsin S has a potent elas-
tolytic activity (38), and therefore the degradative capacity
of lipid-loaded VSMC likely plays a role in the degradation
of existing elastic tissue during atherosclerotic progression.
It was previously reported that cathepsin S is overexpressed
in SMCs of atherosclerosis and neointimal lesions in
humans and animals, and that cathepsin-S-deficient animals
showed reduced fragmentation of elastic lamina in aortas of
atherosclerotic lesions (39). Taken together, these results
point to lipid-loaded VSMCs as crucial players in the loss
of elastin that occurs during atherosclerosis.
We identified FTIR/ATR absorption bands (Fig. 5) of
purified supernatant fractions using bibliographic data on
elastin (40,41), tropoelastin (42,43), k-elastins (40,44), and
FIGURE 4 VSMCs were exposed to agLDL (50 mg/mL) for increasing periods of time (24, 48, and 96 h). (A) RepresentativeWestern blot analysis showing
the time-course of tropoelastin and precursor and mature cathepsin S protein bands in VSMCs exposed to agLDL. Unchanged levels of b-actin are shown as
loading control and used to normalize the tropoelastin and cathepsin S bands. Bar graphs show the quantification of tropoelastin (B), and precursor (C) and
mature (D) cathepsin S bands in control and agLDL-loaded VSMCs. Data are expressed as mean 5 SE of three independent experiments performed in
duplicate. *p < 0.05 versus control VSMC.
Lipid-Loaded Vascular Cells, Tropoelastin Changes 535synthetic polypeptides with recurrent sequences of tropoe-
lastin exons (45,46), and general data on protein FTIR
absorption bands (47,48). The probable band assignments
are shown in Table S1.
The classical absorption bands of proteins (amides A, I,
II, and III) are found on the two spectra, and their positions
are consistent with the literature data on tropoelastin. The
two fractions of supernatants exhibit quite similar profiles,
suggesting very similar chemistry. As shown in Table S2,
the agLDL FTIR spectrum fits very well with literature
data (33), with the very specific absorption of the carbonyl
stretching of ester bond at 1734 cm1.
We can observe a slight shoulder at 1734 cm1 in the
spectrum of supernatant from agLDL-VSMC, indicating
that a weak fraction of agLDL could remain after the
purification, and suggesting an interaction between tropoe-
lastin and agLDL, as previously reported for tropoelastin
and LDL (49).
To obtain more information about the secondary struc-
tures of tropoelastin, we resolved the amide I region of the
supernatant from control VSMC using the Fourier Self
Deconvolution (FSD) procedure (42,50). As shown inFig. 5 B, it resulted in six components that are the signatures
of the different conformations of the protein at 1693 cm1
(antiparallel b-sheets) (40–43,45,51), 1679 cm1 (antipar-
allel b-sheets and b-turns) (41,42,44), 1657 cm1 (irregular
structures/unordered conformations) (43,45,52) or unde-
fined component (40), 1644 cm1 (a-helices) (42,43,53),
1632 cm1 (b-sheets) (41–45,53), and 1617 cm1 (b-sheets)
(42,43,53). Assuming that the area of the different bands is
correlated to the proportion of each kind of conformation,
a quantitative estimation performed on the initial decom-
posed amide I region (with the maxima of the peaks fixed
from the FSD treatment) leads to ~8% of a-helices, 46%
of b-structures, and 46% of unordered/undefined conforma-
tions, which is very close to previously published data for
human elastin (40). The presence of unordered conforma-
tions is confirmed by the vibration at 1542 cm1 in the
amide II band (45,46), and the presence of b-structures is
confirmed by the vibration at 1515 cm1 (44–46). The
band located at 1591 cm1 was not associated with the
particular structure of tropoelastin and may be associated
with another component. Nevertheless, such a band can be
also observed in tropoelastin samples in the literature (50).Biophysical Journal 103(3) 532–540
FIGURE 5 FTIR/ATR spectra of purified supernatants (from control
VSMC and agLDL-loaded VSMC) and pure agLDL (A). FSD trace and
decomposition at 1700–1500 cm1 for supernatant from control VSMCs
(B) and agLDL-loaded VSMCs (C).
FIGURE 6 TGA and DTG of purified supernatants from control VSMCs
and agLDL-loaded VSMCs.
536 Samouillan et al.In the case of the supernatant from agLDL-VSMC, the
decomposition of the amide I band by the FSD protocol pre-
sented in Fig. 5 C yielded seven components at 1693 cm1
(antiparallel b-sheets), 1680 cm1 (antiparallel b-sheets and
b-turns), 1667 cm1, 1657 cm1 (irregular structures/unor-
dered conformations), 1646 cm1 (a-helices), 1632 cm1
(b-sheets) and 1613 cm1 (b-sheets). By analogy to
previous results, the appearance of the vibration at
1667 cm1 could be attributed to irregular structures
(40,43); to another, undefined component (52); or to non-
H-bonded groups (45). This assumption is confirmed by
the intensification of the vibration band at 1555 cm1 in
the amide II region, attributed to non-H-bonded groups.
Thermogravimetric (TG) and derivative thermogravimet-
ric (DTG) plots of purified supernatants from control
VSMCs and from agLDL-VSMCs are presented in Fig. 6.
The mass decrement during the heating process was deter-
mined from the TG curves, and the temperature of the
maximum speed of the process (Tmax) was determined
from the maximum of the DTG curves. The corresponding
thermal parameters for both samples are listed in Table S3.
The global trend of the two TG plots corresponds to the
classical thermal behavior of freeze-dried proteins (54).Biophysical Journal 103(3) 532–540The first stage (between 25C and 100C) is connected to
the evaporation of water absorbed to the protein, and corre-
sponds to 8.2% and 6.4% of the total mass for control and
agLDL-VSMC samples, respectively, meaning that freeze-
dried elastin material from agLDL-VSMC is more hydro-
phobic than that from control VSMC.
The second stage is associated with a multistep stage cor-
responding to the degradation of the sample, namely, a
deamination and depolymerization arising from the
breaking of polypeptidic bonds. The degradation in two
well-marked steps could be due to the presence of both frac-
tions of tropoelastin in the supernatants, with the second
(aggregated one) degrading at higher temperatures. Elastic
material from the agLDL-VSMCs began to degrade at lower
temperatures than the control elastic material, suggesting
that the thermal stability of tropoelastin and aggregated tro-
poelastin are altered when VSMCs are loaded with agLDL.
Superimposed on Fig. 7 are the two thermograms corre-
sponding to the first and second scans of purified superna-
tants recorded at 20C/min between 30C and 180C, and
60C and 250C, respectively. In accordance with
previous studies (42,54), the first scan performed between
30C and 180C is characteristic of water-protein interac-
tions, and generally presents the feature of a broad endo-
thermic peak associated with the departure of bound
water. The broadness of the peak can be explained by
the complexity of the transition, which must include disrup-
tion of protein-water interactions, evaporation, and vapor-
ization (54–56). The enthalpy associated with this
transition is connected to the water content of the superna-
tant: the largest value of the enthalpy is found for superna-
tants from control VSMCs (160J/g vs. 120 J/g), which
means that this fraction corresponds to the more-hydrated
sample in accordance with TGA data. Superimposed on
this broad transition are other events that can be associated
with the thermal answer of proteins. The second scans
FIGURE 7 Second DSC thermograms of purified supernatants from
control and agLDL-loaded VSMCs.
FIGURE 8 DDS isotherms of purified supernatant from control VSMCs.
(A) The b-mode between70C and30C. (B) The a-mode between 5C
and 60C.
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characteristics of dehydrated proteins (50,54). Two major
glass transitions are observed for the two samples as
a step of the heat flow (the glass transition temperatures
Tg are reported in the graph).
The presence of two glass transitions is indicative of two
kinds of amorphous phases in the purified supernatants, and
corroborates the TGA measurements showing different
stabilities of tropoelastin. According to literature data, the
only transition that is detectable for native elastin and tro-
poelastin is a glass transition, namely, a pseudo-second-
order transition due to the transition from a glassy to a rubber
state at ~200C for dehydrated elastin and tropoelastin
(42,50,54,57,58). Elastin does not possess a long-range
order, and although different secondary conformations can
be found in this protein, it can be considered as amorphous
for the physical structure, which is in good agreement with
the model of labile, dynamic b-turns in hydrophobic
domains proposed by Debelle and Tamburro (31) and Tam-
burro et al. (32), and Li et al.’s (59) model that describes
hydrophobic domains of elastin as compact amorphous
structures.
In accordance with these previous studies, the second
glass transition (at Tg2 ¼ 200.1C) of supernatant from
control VSMCs could be attributed to the thermal character-
istics of aggregated tropoelastin. The lower glass transition
(at Tg1¼ 41.4C) could be attributed to nonaggregated tro-
poelastin. In the case of supernatant from agLDL-VSMC,
both tropoelastin and aggregated tropoelastin undergo
a glass transition at lower temperature, with a spectacular
decrease of the glass transition associated with aggregated
tropoelastin (Tg2 ¼ 159C). This phenomenon could be
due to an interaction between agLDL and tropoelastin, as
evidenced by the weak specific FTIR absorption band of
agLDL in supernatant from agLDL-loaded VSMCs.Superimposed on Fig. 8, A and B, are the isotherms of tan
d recorded for supernatant from control VSMCs in different
temperature ranges. The experiments were stopped at 100C
because a substantial conductivity at higher temperatures
was hiding possible dipolar relaxations.
In this temperature range, three modes can be observed
and associated with dipolar relaxations. The lower tempera-
ture mode (Fig. 8 A) is observed from 70C to 30C and
labeled b-mode by analogy with previous works on proteins
(58–61); the higher temperature mode (Fig. 8 B) is observed
between 5C and 60C and labeled a-mode. A minor inter-
mediate mode (not shown) is observed as a shoulder at
15C and 10C and labeled a0-mode. For each tempera-
ture, the frequency of the maximum is noted, and the asso-
ciated relaxation time t(T) is computed using the following
formula:
tðTÞ ¼ 1ð2pfmaxÞ: (1)
The temperature dependence of the dipolar modes can be
reached by plotting the variation of t(T) versus temperature.
In Fig. 9 A, we plot the variation of the relaxation times in
a logarithmic scale versus temperature in an offset recip-
rocal scale for the a-, a0-, and b-modes of supernatant
from control VSMCs.Biophysical Journal 103(3) 532–540
FIGURE 9 Temperature dependence of the three dipolar modes of puri-
fied supernatant from control VSMCs (A) and agLDL-loaded VSMCs (B).
538 Samouillan et al.A linear relationship is obtained for the b- and a-modes,
revealing that t(T) follows an Arrhenius law:
tðTÞ ¼ t0 exp

Ea
RT

; (2)
where t0 is the preexponential factor, R is the gas constant,
and Ea is the activation energy.
The corresponding values computed from a linear fit are
reported in Fig. 9 A.
The values of t0 (10
15 s) and Ea (50 kJ$mol1) of the
b-mode are typical of the classical and universal secondary
process in proteins (62): the value of the activation energy
corresponds to the energy required to break two H-bonds,
allowing the further reorientation of the dipole. The preex-
ponential factor t0 is associated with the activation entropy
DS in Eyring’s equation:
t0 ¼ hðkTÞ exp
DS
R

; (3)
where h is Planck’s constant and k is Boltzmann’s constant.
The value of 1015 s corresponds to a weak activation
entropy (DSz40 J$K1$mol1) and is indicative of a small
cooperative mode. The b-mode can be thus associated with
the dipolar relaxation of carbonyl groups of the protein
bound to water (60).
As for the a-mode, the values of t0 (10
25 s) and Ea
(126 kJ$mol1) are characteristic of the main process inBiophysical Journal 103(3) 532–540proteins: the preexponential factor corresponds to an impor-
tant activation entropy (DSz234 J$K1$mol1), indicative
of a cooperative mode (63), and the a-mode is thus associ-
ated with the dielectric manifestation of the first glass tran-
sition of tropoelastin (observed by DSC at Tg1¼ 41.4C),
implying motions of some tens of nanometers along the
polypeptidic backbone. Because the a-process has an Arrhe-
nius-like behavior, tropoelastin possesses a strong network
of H-bonds, as previously observed for different fibrous
proteins (35).
The same dielectric protocol was applied to supernatant
from agLDL-loaded VSMCs. As with the control sample,
three relaxation modes labeled b, a, and a0 were observed
in this temperature range. The logarithmic variation of the
relaxation time t(T) versus temperature is plotted for each
mode in Fig. 9 B.
As with the control sample, the relaxation time of the
b-mode has an Arrhenius-like temperature dependence.
The values of the Arrhenius parameters reported in Fig. 9
B are roughly similar, meaning that the localized motions
along the backbone of tropoelastin are roughly the same
for the two supernatants.
The a-mode that was previously associated with the tro-
poelastin glass transition is shifted toward low temperature
(~10C), in accordance with the DSC results. Moreover,
the temperature dependence of the relaxation time follows
a Vogel-Fulcher-Tamman (VFT) behavior, in contrast to
the Arrhenius-like behavior observed for the relaxation
time of control tropoelastin. The corresponding function is
written as
tðTÞ ¼ t0 exp

B
ðT T0Þ

: (4)
The corresponding values of t0, B, and T0 are reported in
Fig. 9, A and B.
The important discrepancy observed between the delocal-
ized motions along the polypeptidic backbone of tropoelas-
tin from control and agLDL-loaded VSMCs can be
interpreted in terms of differences between the H-bond
network density of the two systems: In a general way, an
Arrhenius-like behavior is connected to a strong H-bond
network, whereas a VFT-like behavior is attributed to a
more loosely bound H-bond network (50). These results
suggest that tropoelastin possesses more non-H-bonded
groups when VSMCs are agLDL-loaded, as previously
shown by FTIR. This could be due in part to the interaction
between agLDL and tropoelastin (as revealed by FTIR anal-
ysis) modifying its secondary structure and aggregation.CONCLUSION
Aggregation of LDL is one of the main mechanisms by
which VSMCs become foam cells during atherosclerosis;
however, the role played by agLDL in the inability of
Lipid-Loaded Vascular Cells, Tropoelastin Changes 539VSMCs to produce normal elastic fibers in atherosclerosis
is almost completely unknown. Here, we show that agLDL
loading reduced the cellular elastogenic capacity and
increased the elastolytic potential of human VSMCs. The
physical analysis showed modifications of secreted tropoe-
lastin when VSMCs were agLDL-loaded. First, the affinity
with water was decreased, suggesting a loss of elasticity
because water is essential for the elasticity of elastin. At
the conformational level, the results revealed a new (to
our knowledge), undefined, probably non-H-bonded struc-
ture for tropoelastin that could be due to an interaction of
the protein with remaining agLDL, inducing the distinct
chain dynamics of tropoelastin evidenced by dielectric anal-
ysis and the decrease of the glass transition of tropoelastin
and aggregated tropoelastin. These alterations in the phys-
ical structure of tropoelastin will unfailingly induce alter-
ations in the mechanical properties of elastic fibers, in
particular a loss of the rubber-like properties and a loss of
the reversibility during deformations that may favor the
rupture of the macromolecule. Indeed, the increased degra-
dative capacity of agLDL-loaded VSMCs may contribute to
the physical alterations of secreted tropoelastin. Moreover,
the degradative capacity of lipid-loaded VSMCs may play
a role in the degradation of existing elastic tissue during
atherosclerotic progression.
Taken together, our results suggest that VSMC intracel-
lular lipids provoke crucial alterations in cellular tropoelas-
tin levels, mechanical properties, and capacity to break
down elastin. Moreover, our results point to lipid-loaded
VSMCs as crucial players in the loss of elastin during
atherosclerosis.SUPPORTING MATERIAL
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